March 2013 FDA Recall Diclofenac Sodium And Misoprostol by Watson Laboratories, Inc.-(actavis) - Florida
D-817-2013 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Watson Laboratories, Inc.-(actavis) - Florida on March 22, 2013 for the product Diclofenac Sodium And Misoprostol. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-817-2013

Reason for Recall
Failed Tablet/Capsule Specifications: Broken tablets
Initiated
03-22-2013
Reported
07-31-2013
Quantity
392,400 tablets

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Watson Laboratories, Inc.-(Actavis) - Florida
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75mg/0.2mg, 60-count bottle, Rx only, Manufactured by Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60

Batch or Lot Expiration Information

Lot# Lot 635098A, Exp 10/14